Research Article
Mortality in Iranian Patients with Parkinson’s Disease: Cumulative Impact of Cardiovascular Comorbidities as One Major Risk Factor
Table 1
Baseline and clinical characteristics of the recruited Parkinson’s disease patients.
| | Characteristics | Total
() |
| | Current age (or death age) (yr) mean (SD) | 63.6 (11.0) | | Age at the time of diagnosis (yr) mean (SD) | 55.5 (12.1) | | Sex (%) | | | Female | 59 (31.1) | | Male | 131 (68.9) | | Family history of parkinsonism (%) | 31 (16.4) | | Level of education (%) | | | Illiterate | 17 (9.1) | | Primary and/or secondary | 63 (33.7) | | High school/diploma | 51 (27.3) | | College and/or university | 56 (29.9) | | Marital status (%) | | | Single | 9 (5.6) | | Married | 127 (78.9) | | Widow or divorced | 25 (15.5) | | Treatment history (%) | | | Levodopa | 181 (96.3) | | Amantadine | 70 (37.2) | | Selegiline | 16 (8.5) | | Bipyridine | 6 (3.2) | | Other dopaminergic drugs (i.e., ropinirole and pramipexole) | 58 (30.9) | | Deep brain stimulation (DBS) | 8 (4.2) | | Comorbidities (%) | | | Heart failure | 34 (18.0) | | Hypertension | 38 (20.1) | | Diabetes | 24 (12.7) | | Stroke | 10 (5.3) | | Respiratory diseases | 20 (10.6) | | Depression | 87 (46.0) | | Dementia | 36 (19.0) |
|
|
